Vanguard Group’s DarioHealth DRIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.13M | Buy |
99,301
+68,897
| +227% | +$908K | ﹤0.01% | 3741 |
|
|
2025
Q3 | $528K | Buy |
30,404
+12,220
| +67% | +$135K | ﹤0.01% | 3931 |
|
|
2025
Q2 | $244K | Hold |
18,184
| – | – | ﹤0.01% | 4056 |
|
|
2025
Q1 | $223K | Hold |
18,184
| – | – | ﹤0.01% | 4050 |
|
|
2024
Q4 | $286K | Hold |
18,184
| – | – | ﹤0.01% | 4051 |
|
|
2024
Q3 | $407K | Hold |
18,184
| – | – | ﹤0.01% | 4020 |
|
|
2024
Q2 | $433K | Hold |
18,184
| – | – | ﹤0.01% | 4046 |
|
|
2024
Q1 | $556K | Buy |
18,184
+32
| +0.2% | +$1.21K | ﹤0.01% | 3988 |
|
|
2023
Q4 | $624K | Buy |
18,152
+3,052
| +20% | +$109K | ﹤0.01% | 3969 |
|
|
2023
Q3 | $991K | Buy |
15,100
+673
| +5% | +$45.3K | ﹤0.01% | 3831 |
|
|
2023
Q2 | $1.16M | Hold |
14,427
| – | – | ﹤0.01% | 3857 |
|
|
2023
Q1 | $1.19M | Hold |
14,427
| – | – | ﹤0.01% | 3867 |
|
|
2022
Q4 | $1.23M | Buy |
14,427
+21
| +0.1% | +$1.89K | ﹤0.01% | 3837 |
|
|
2022
Q3 | $1.33M | Buy |
14,406
+3,522
| +32% | +$378K | ﹤0.01% | 3903 |
|
|
2022
Q2 | $1.34M | Sell |
10,884
-2,766
| -20% | -$325K | ﹤0.01% | 3986 |
|
|
2022
Q1 | $1.59M | Buy |
13,650
+702
| +5% | +$116K | ﹤0.01% | 4051 |
|
|
2021
Q4 | $3.36M | Buy |
12,948
+185
| +1% | +$56.3K | ﹤0.01% | 3823 |
|
|
2021
Q3 | $3.48M | Buy |
12,763
+276
| +2% | +$79.6K | ﹤0.01% | 3850 |
|
|
2021
Q2 | $5.33M | Buy |
12,487
+6,960
| +126% | +$2.65M | ﹤0.01% | 3563 |
|
|
2021
Q1 | $2.13M | Buy |
5,527
+366
| +7% | +$165K | ﹤0.01% | 3845 |
|
|
2020
Q4 | $1.48M | Buy |
5,161
+195
| +4% | +$50.3K | ﹤0.01% | 3731 |
|
|
2020
Q3 | $1.67M | Buy |
+4,966
| New | +$1.34M | ﹤0.01% | 3535 |
|
|
2019
Q4 | – | Sell |
-273
| Closed | -$33K | – | 4126 |
|
|
2019
Q3 | $33K | Hold |
273
| – | – | ﹤0.01% | 4108 |
|
|
2019
Q2 | $51K | Hold |
273
| – | – | ﹤0.01% | 4105 |
|
|
2019
Q1 | $80K | Buy |
273
+5
| +2% | +$1.49K | ﹤0.01% | 4026 |
|
|
2018
Q4 | $83K | Hold |
268
| – | – | ﹤0.01% | 4019 |
|
|
2018
Q3 | $104K | Hold |
268
| – | – | ﹤0.01% | 4072 |
|
|
2018
Q2 | $137K | Buy |
268
+237
| +765% | +$155K | ﹤0.01% | 4025 |
|
|
2018
Q1 | $19K | Buy |
31
+4
| +15% | +$2.44K | ﹤0.01% | 4090 |
|
|
2017
Q4 | $18K | Hold |
27
| – | – | ﹤0.01% | 4052 |
|
|
2017
Q3 | $20K | Hold |
27
| – | – | ﹤0.01% | 4058 |
|
|
2017
Q2 | $24K | Buy |
+27
| New | +$28.1K | ﹤0.01% | 4062 |
|
Other funds holding DRIO
NCM
KAS
TRCT
TCOT
SS
Vanguard Group's DRIO Position: Q4 2025 in Review
Vanguard Group increased its DarioHealth (DRIO) stake by 227% in Q4 2025, buying an estimated $908K and bringing the position to 99,301 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #3741.
Vanguard Group first reported a position in DRIO in Q2 2017 and has held it in 32 quarters since. The position peaked at $5.33M in Q2 2021. 17 funds tracked by Wall St. Rank hold DRIO as of Q4 2025.
- Vanguard Group held 99,301 shares of DarioHealth worth $1.13M as of Q4 2025.
- Vanguard Group bought 68,897 DarioHealth shares in Q4 2025, an estimated $908K.
- DarioHealth made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3741 holding.
- Vanguard Group first reported a position in DarioHealth in Q2 2017 and has held it in 32 quarters since.
- Vanguard Group's DarioHealth position peaked at $5.33M in Q2 2021.
- 17 funds tracked by Wall St. Rank held DarioHealth as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.